Anthem Biosciences Limited share price
NSE: ANTHEM · ISIN INE0CZ201020
Key numbers
- Market cap
- ₹ 49,071 Cr
- Current price
- ₹ 873.60
- 52-week high / low
- ₹ 978 / 579
- Stock P/E
- 86.5
- Book value
- ₹ 54.2
- Dividend yield
- 0.23%
- ROCE
- 29.6%
- ROE
- 21.7%
- Debt to equity
- 0.02
- Sales growth (3 yrs)
- 26.2%
- Profit growth (3 yrs)
- 15.4%
- 1-year return
- 6.4%
About Anthem Biosciences Limited
Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients. The company offers contract research development and manufacturing services, such as end-to-end services across the new chemical entity and new biological entity lifecycles, as well as engages in contract research, development, and manufacturing of development batches of molecules used for clinical trials up to commercial manufacturing for small molecules and biologics. It also manufactures and sells specialized fermentation-based active pharmaceutical ingredients, including probiotics, enzymes, peptides, nutritional actives, vitamin analogues, and biosimilars. The company was incorporated in 2006 and is based in Bengaluru, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 540 | 550 | 423 | 611 | 418 |
| Operating profit | 192 | 218 | 157 | 267 | 151 |
| Net profit | 136 | 173 | 93 | 190 | 120 |
| EPS (₹) | 2.42 | 3.09 | 1.65 | 3.38 | 2.13 |
Peers in Biotechnology
Data for information only, not investment advice. Prices end of day.